February 2023

NEWS & COLUMNS

6-7 NEWS
AstraZeneca to acquire CinCor Pharma for $1.8bn; WHO launches $2.54bn emergency health appeal

8-9 NEWS
California sues largest US insulin manufacturers and PBMs; NICE recommends wider use of statins

10-11 CORONAVIRUS NEWS
WHO releases latest COVID-19 guidelines; GSK and Curevac advance COVID-19/flu vaccine candidate

12 DARWIN'S MEDICINE
How innovation may be becoming less innovative

13 POLICY AND PUBLIC HEALTH
California tried to tell doctors what would be classified as misinformation – it didn’t go well

14 PRO BONO PUBLICO
Seven key principles for success for pro bono working

15 INNOVATIVE IMPACT BLOG
In these uncertain times, plan for the actions you may never take

FEATURES

16-17 WORLD CANCER DAY 2023
Exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients

18-19 LIFE SCIENCES REIMAGINED
Reassessing future priorities in the wake of the pandemic

20 ALZHEIMER'S RESEARCH
Alzheimer’s Society and Alzheimer’s Research UK are urging the government to deliver on its dementia plans, as they highlight the need for more government support

22 MANAGING COPD: THE 2023 GOLD REPORT
The annual report provides new, essential updates on screening, therapeutic interventions and adherence

23 A RELENTLESS COMMITMENT TO NEUROSCIENCE
Hundreds of millions of people worldwide are affected by neurological and psychiatric disorders, the largest global cause of disability

16. World Cancer Day 2023